Hjem › Myelodysplastiske syndromer › New Hampshire
Kliniske studier for Myelodysplastiske syndromer i New Hampshire
5 studier for Myelodysplastiske syndromer søker deltakere på steder i New Hampshire.
Offisiell studietekst (engelsk)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564390Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06577441The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Dartmouth-Hitchcock, Lebanon
RekruttererObservasjonsstudie
Opp til 30 år · Alle kjønn · Oppdatert 16. jul. 2026 · NCT04968834Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Dana Farber/New Hampshire Oncology-Hematology, Londonderry
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 7. mai 2026 · NCT02269592Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.